Follicle Stimulating Hormone
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
FSH is a sterile, lyophilized powder intended for subcutaneous (SC) or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection. It contains 75 IU & 150 IU of Follicle Stimulating Hormone (FSH) per vial.
It is unsafe to consume alcohol while using FSH 75IU IM/SC Injection.
FSH 75IU IM/SC Injection is highly unsafe to use during pregnancy. Consult your doctor for advice, as studies on pregnant women and animals have shown significant harmful effects on the developing baby.
Information regarding the use of FSH 75IU IM/SC Injection during breastfeeding is not available. Please consult your doctor before using this medication while breastfeeding.
FSH 75IU IM/SC Injection does not usually affect your ability to drive.
Limited information is available on the use of FSH 75IU IM/SC Injection in patients with kidney disease. Please consult your doctor before using this medication if you have kidney issues.
Limited information is available on the use of FSH 75IU IM/SC Injection in patients with liver disease. Please consult your doctor before using this medication if you have liver problems.
In females, FSH 75 IU stimulates the release of estrogen, aiding in egg development. It also helps develop more follicles (eggs) in women undergoing assisted reproductive technology procedures.
FSH 75 IU is primarily used in the treatment of female infertility. It helps stimulate the release of estrogen, promoting the growth and development of eggs before release. This medication is administered as an injection under the supervision of a doctor.
FSH stimulates ovarian follicular growth in women who do not have primary ovarian failure. Treatment with FSH results in follicular growth and maturation, requiring HCG to induce ovulation.
There are no significant pharmacokinetic differences between intramuscular and subcutaneous administration of FSH. Both routes have an absolute bioavailability of approximately 77 percent.
Acute toxicity data in humans are not available. Overdose may lead to ovarian hyperstimulation syndrome.
Your doctor or nurse will administer this medication. Do not self-administer.
No drug/drug interaction studies have been conducted for Urofollitropin in humans
FSH is contraindicated during pregnancy and lactation (Category X).
vQ1:
Q2:
Q3:
Q4:
Q5:
Q6:
Q7:
Q8:
Q9:
Q10:
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.